General
Peptide: | SMAP-29 |
Microorganism: | Staphylococcus aureus |
Administration: | |
Stage: | Preformed biofilm |
Notes: | Sa4 clinical isolate |
Experimental procedure
Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
---|---|---|---|
Total countable CFUs | Not Active | 1.251 uM | |
Total countable CFUs | 21 - 50% | 6.256 uM | |
Total countable CFUs | 51 - 90% | 12.512 uM |
Reference
- A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com